Genomic testing dictates how precision cancer medicines, chemotherapy & surgery are used to treat advanced colon cancer

Checkpoint inhibitors superior to chemotherapy as initial treatment of advanced Microsatellite Instability-High (MSI-H)

Connect with Others at Top Cancer Centers - Second Opinion Options...

Onvansertib gets FDA fast track approval-Initial data released at ESMO 2020 demonstrates effectiveness in KRAS patients.

Surgery followed by chemotherapy can improve outcomes for patients with colon cancer and operable liver metastases

Combination of Stivarga with a checkpoint inhibitor could help overcome immunotherapy resistance and improve outcomes.

Specific treatment for colon cancer is based on the stage and genomic profile of each persons unique colon cancer.

Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy